Vicarious Surgical Inc (NYSE:RBOT – Get Free Report) was the target of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 110,800 shares, a growth of 30.4% from the February 13th total of 85,000 shares. Based on an average daily trading volume, of 48,500 shares, the short-interest ratio is presently 2.3 days. Approximately 2.1% of the company’s shares are short sold.
Vicarious Surgical Stock Performance
RBOT opened at $8.20 on Wednesday. The firm’s fifty day moving average is $12.56 and its two-hundred day moving average is $10.60. The firm has a market cap of $48.42 million, a PE ratio of -0.80 and a beta of 1.35. Vicarious Surgical has a twelve month low of $4.27 and a twelve month high of $19.00.
Vicarious Surgical (NYSE:RBOT – Get Free Report) last posted its earnings results on Monday, March 17th. The company reported ($2.43) earnings per share for the quarter, topping the consensus estimate of ($2.69) by $0.26. The firm had revenue of $2.09 million during the quarter. During the same quarter in the previous year, the business posted ($2.25) EPS. Equities analysts forecast that Vicarious Surgical will post -10.89 EPS for the current fiscal year.
Analysts Set New Price Targets
View Our Latest Stock Analysis on Vicarious Surgical
Institutional Investors Weigh In On Vicarious Surgical
Several hedge funds have recently bought and sold shares of the company. Renaissance Technologies LLC raised its holdings in Vicarious Surgical by 11.6% in the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock worth $152,000 after purchasing an additional 1,200 shares during the period. Geode Capital Management LLC increased its position in shares of Vicarious Surgical by 8.2% during the fourth quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock worth $405,000 after acquiring an additional 2,336 shares in the last quarter. Finally, DnB Asset Management AS increased its position in shares of Vicarious Surgical by 21.1% during the fourth quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock worth $279,000 after acquiring an additional 3,692 shares in the last quarter. 47.27% of the stock is currently owned by institutional investors and hedge funds.
Vicarious Surgical Company Profile
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Read More
- Five stocks we like better than Vicarious Surgical
- Stock Dividend Cuts Happen Are You Ready?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How to Calculate Inflation Rate
- 3 Must-Own Stocks to Build Wealth This Decade
- What is the Dogs of the Dow Strategy? Overview and Examples
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.